| §Cryptogenic HCC (n = 18) | HBV-HCC (n = 36) | *p | HCV-HCC (n = 36) | **p | ¶ ALC-HCC | ***p |
---|---|---|---|---|---|---|---|
 |  |  |  |  |  | (n = 23) |  |
Age (yr) †| 70.3 ± 10.6 | 67.4 ± 9.1 | 0.201 | 69.0 ± 8.8 | 0.646 | 67.7 ± 9.6 | 0.510 |
Gender, male††| 9 (50.0) | 9 (50.0) | 1.000 | 9 (50.0) | 1.000 | 18 (78.3) | 0.097 |
BMI (kg/m2) †| 24.7 ± 3.0 | 23.3 ± 3.1 | 0.196 | 22.8 ± 3.2 | 0.050 | 24.5 ± 4.9 | 0.415 |
VFA (cm2) †| 134.4 ± 53.9 | 100.0 ± 51.3 | 0.037 | 105.0 ± 51.1 | 0.034 | 136.9 ± 64.9 | 0.599 |
Liver attenuation (HU) †| 54.3 ± 5.5 | 53.7 ± 5.8 | 0.533 | 53.5 ± 6.7 | 0.441 | 50.7 ± 8.3 | 0172 |
Spleen attenuation (HU) †| 44.0 ± 4.5 | 43.7 ± 4.0 | 0.263 | 45.0 ± 3.8 | 0.734 | 44.0 ± 5.0 | 0.743 |
Liver/Spleen ratio†| 1.24 ± 0.14 | 1.23 ± 0.14 | 0.854 | 1.20 ± 0.14 | 0.419 | 1.15 ± 0.14 | 0.066 |